Initial award funds process development, manufacturing, and clinical evaluation of a single-dose vaccine candidate through strategic partnerships with Hilleman Laboratories,...
Company Announcement COPENHAGEN, Denmark; October 28, 2026 Phase 3 LiGeR-HN1 trial of Petosemtamab in combination with pembrolizumab versus pembrolizumab alone...
Published multicenter clinical trial data demonstrate higher wound closure rates and greater wound area reduction with XWRAP® plus standard of...
The first intradiscal allograft to succeed in a rigorous, sham-controlled trial for chronic lumbar discogenic pain, a leading driver of...
MIAMI, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (the “Company”) (NASDAQ: LGVN), today announced that the Company has retained...
SLO-RP Preserve trial sites actively enrolling FORT WORTH, Texas, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, Inc., a clinical-stage...
First joint project launches a broader platform strategy for process orchestration across the clinical trial lifecycle BERLIN, Oct. 28, 2026...
BOSTON, Oct. 28, 2026 /PRNewswire/ -- Empatica, a leader in digital biomarker development and clinical-grade wearable technology, today announced WellPD,...
Expands access to high-resolution, single-cell genomic analysis throughout cell and gene therapy developmentBOULDER, Colo., Oct. 27, 2026 /PRNewswire/ -- KROMATID,...
Mission: Cure joins FDA's Rare Disease Endpoint Advancement Pilot Program as the agency calls for putting the patient's voice at...
Filament has signed a supply and licensing agreement with Linköping University in Sweden for PEX010 in the PsiloSAD clinical trial...
AFRRI study found no evidence of treatment-related toxicity following a single dose of Entolimod, supporting advancement toward a planned, fully...
Engagement to support expanded investor outreach as BetterLife advances BETR-001 toward planned clinical development in 2027Vancouver, British Columbia--(Newsfile Corp. -...
CREATE will bring together leaders in cell therapy and rheumatology to discuss why in vivo CAR-T is poised to become...
70% in vivo editing of human APOC3 in a single administration76% triglyceride reduction after a single dose in murine disease...
DELRAY BEACH, Fla., Oct. 26, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Patient Registry Software Market is projected to reach USD...
As drug pipelines grow faster than site capacity, Florence moves from storing trial work to doing it, with research teams...
MIAMI, Oct. 26, 2026 /PRNewswire/ -- BreakBio, a biotech company developing personalized drugs for cancer, today announced that Stephen M....
The TUXEDO-3 study evaluates the efficacy of patritumab deruxtecan (HER3-DXd) for treating active brain metastases in patients with metastatic breast...
Ten patients initially deemed unfit for intensive chemotherapy proceeded to stem cell transplantTransplant rate compares favorably with historical standard-of-care experience,...